Alzheimer's disease (AD) is a devastating and progressive neurodegenerative disease for
which there is no cure. Mild cognitive impairment (MCI) is considered a prodromal stage of …

Abstract Alzheimer's disease (AD), the most common form of dementia worldwide, is a mixed
proteinopathy (β-amyloid, tau and other proteins). Classically defined as a …

Introduction Differential patterns of brain atrophy on structural magnetic resonance imaging
(MRI) revealed four reproducible subtypes of Alzheimer's disease (AD):(1)“typical”,(2)“limbic …

The linguistic and anatomical variability of the logopenic variant of Primary Progressive
Aphasia (lv-PPA) as defined by current diagnostic criteria has been the topic of an intense …

Alzheimer disease (AD), the most common form of dementia, is a heterogenous disorder
with various pathobiological subtypes. In addition to the 4 major subtypes based on the …

The mechanisms through which tau and amyloid-beta (Aβ) accumulate in the brain of
Alzheimer's disease patients may differ but both are related to neuronal networks. We …

Alzheimer's disease can present clinically with either the typical amnestic phenotype or with
atypical phenotypes, such as logopenic progressive aphasia and posterior cortical atrophy …

According to the network model of neurodegeneration, the spread of pathogenic proteins
occurs selectively along connected brain regions. We tested in vivo whether the distribution …

Alzheimer disease (AD), the most common form of dementia globally, classically defined a
clinicopathological entity, is a heterogenous disorder with various pathobiological subtypes …

Alzheimer's disease (AD) can present with atypical clinical forms where the prominent
domain of deficit is not memory, that is, atypical AD. Atypical AD patients show cortical …